METASTATIC GENITOURINARY SYSTEM CARCINOMA

Clinical trials for METASTATIC GENITOURINARY SYSTEM CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC GENITOURINARY SYSTEM CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC GENITOURINARY SYSTEM CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets Cancer's weak spot: a hopeful trial for Tough-to-Treat tumors

Disease control Recruiting now

This study is testing whether a pill called olaparib can help control advanced bladder and other urinary cancers that have specific DNA repair defects and have stopped responding to standard treatments like chemotherapy. The drug works by blocking a protein that helps cancer cell…

Matched conditions: METASTATIC GENITOURINARY SYSTEM CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

METASTATIC GENITOURINARY SYSTEM CARCINOMA

Get alerted when new METASTATIC GENITOURINARY SYSTEM CARCINOMA trials appear

New pill targets Cancer's weak spot: a hopeful trial for Tough-to-Treat tumors